Global Epilepsy Therapeutics Market - Industry Analysis, Trends and Forecast, 2013 – 2019

Transparency Market Research Reports incorporated a definite business overview and investigation inclines on “Epilepsy Therapeutics Market”. This report likewise incorporates more illumination about fundamental review of the business including definitions, requisitions and worldwide business sector industry structure. Epilepsy is a group of long-term neurological disorders that is characterized by recurring seizures. These seizures are episodes that occur when group of nerve cells or neurons in brain sends wrong signals. Seizures could differ from primary generalized seizures to partial seizures depending upon the cause of the epilepsy. Patients suffering from epilepsy may complain about strange emotions and sensations or they may behave strangely.

Browse Full Report with TOC: http://www.transparencymarketresearch.com/epilepsy-therapeutics-market.html

Epilepsy is the fourth most common brain disorder affecting people of all ages. For the treatment of epilepsy, doctors prescribe antiepileptic medicines (AEDs) and the preference for the drug depends on the type of seizures to be treated, age of the patient, part of the brain involved and seriousness of the seizures. On the basis of the available AEDs, epilepsy therapeutics market is segmented into two major categories namely first generation AEDs and second generation AEDs. First generation AEDs consist of following drugs:

Carbamazepine (Carbatrol)

Valproate (Depakote)

Oxycarbazepine ((Trileptal)

Phenytoin (Dilantin, Phenytek)

Ethosuximide (Zarontin)

Phenobarbital (Luminal)

Primidone (Mysoline)

Topiramate (Topamax)

Second generation AEDs consist of medicines with different mechanism of action than the first generation drugs. This segment of epilepsy therapeutics market consists of following drugs:

Pregabalin (Lyrica)

Lamotrigine (Lamictal)

Levetiracetam (Keppra)

Zonisamide (Zonegran)

Lacosamide (Vimpat)

Eslicarbazepine acetate...